Actionable news
All posts from Actionable news
Actionable news in CRVS: Corvus Pharmaceuticals Inc,

Corvus Pharmaceuticals to Present at AACR Annual Meeting April 16 – 20 in New Orleans

BURLINGAME, Calif., April 05, 2016 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (CRVS), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel immuno-oncology therapies, today announced oral and poster presentations of key preclinical data relating to certain of its drug development programs at the American Association of Cancer Research (AACR) Annual Meeting, April 16-20, 2016 in New Orleans.

Following are the specifics for Corvus’ two poster presentations:

  • Inhibition of Adenosine A2A Receptor (A2AR) by CPI-444 Enhances CD8+ T cell Killing of a HER-2/neu Expressing Murine Tumor
Authored by Blake A. Scott1, Todd Armstrong2, Elizabeth M. Jaffee2
Affiliations: 1Johns Hopkins University School of Medicine, Baltimore, MD; 2Sidney Kimmel Comprehensive Cancer Center Johns Hopkins University School of...